{"id":24259,"date":"2018-02-14T12:00:00","date_gmt":"2018-02-14T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/"},"modified":"2018-02-14T12:00:00","modified_gmt":"2018-02-14T12:00:00","slug":"allergeen-immunotherapie-kan-astmapreventie-worden-bereikt","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/","title":{"rendered":"Allergeen-immunotherapie: Kan astmapreventie worden bereikt?"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1489 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Brussel 2017<\/h2>\n<p>Preventie van astma bij pati\u00ebnten met allergische rhinitis kan worden bereikt, maar er is geen sprake van een generiek klasse-effect, waardoor experts in het veld niet kunnen bevestigen dat alle AIT-producten dit doel kunnen bereiken. Het bewijs vertoont tot nu toe onvolkomenheden, maar er is een langetermijnstudie van Mola die keek naar allergeen-immunotherapie bij kinderen met graspollenallergie; hieruit bleek dat degenen die therapie kregen minder kans hadden om astma te ontwikkelen. <\/p>\n<p>Deze interviews zijn opgenomen tijdens de Rhinology Future Debates Brussel 2017 met Oliver Pfaar, David Price en Glenis Scadding.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1490 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"YouTube-videospeler\" src=\"https:\/\/www.youtube.com\/embed\/fDb7aQAp4zI?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Brussel 2017 Preventie van astma bij pati\u00ebnten met allergische rhinitis kan worden bereikt, maar er is geen sprake van een generiek klasse-effect, waardoor experts in het veld niet kunnen bevestigen dat alle AIT-producten dit doel kunnen bereiken. Het bewijs vertoont tot nu toe onvolkomenheden, maar er is een langetermijnstudie van Mola die keek naar allergeen-immunotherapie bij kinderen met graspollenallergie; hieruit bleek dat degenen die therapie kregen minder kans hadden om astma te ontwikkelen. Deze interviews zijn opgenomen tijdens de Rhinology Future Debates Brussel 2017 met Oliver Pfaar, David Price en Glenis Scadding.<\/p>\n","protected":false},"author":1,"featured_media":24266,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[233],"tags":[154,164,223,234,235,236,237],"class_list":["post-24259","news","type-news","status-publish","has-post-thumbnail","hentry","category-rhinology-future-debates","tag-zorgverleners","tag-allergische-rhinitis-ar","tag-astma","tag-rhinologie","tag-debatten","tag-rhinology-future-debates","tag-allergeen-immunotherapie-ait"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Allergeen-immunotherapie: Kan astmapreventie worden bereikt? - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Allergeen-immunotherapie: Kan astmapreventie worden bereikt?\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Brussel 2017 Preventie van astma bij pati\u00ebnten met allergische rhinitis kan worden bereikt, maar er is geen sprake van een generiek klasse-effect, waardoor experts in het veld niet kunnen bevestigen dat alle AIT-producten dit doel kunnen bereiken. Het bewijs vertoont tot nu toe onvolkomenheden, maar er is een langetermijnstudie van Mola die keek naar allergeen-immunotherapie bij kinderen met graspollenallergie; hieruit bleek dat degenen die therapie kregen minder kans hadden om astma te ontwikkelen. Deze interviews zijn opgenomen tijdens de Rhinology Future Debates Brussel 2017 met Oliver Pfaar, David Price en Glenis Scadding.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\\\/\",\"name\":\"Allergeen-immunotherapie: Kan astmapreventie worden bereikt? - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png\",\"datePublished\":\"2018-02-14T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/kies-uw-traject\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Allergeen-immunotherapie: Kan astmapreventie worden bereikt?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Allergeen-immunotherapie: Kan astmapreventie worden bereikt? - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/","og_locale":"nl_NL","og_type":"article","og_title":"Allergeen-immunotherapie: Kan astmapreventie worden bereikt?","og_description":"Rhinology Future Debates Brussel 2017 Preventie van astma bij pati\u00ebnten met allergische rhinitis kan worden bereikt, maar er is geen sprake van een generiek klasse-effect, waardoor experts in het veld niet kunnen bevestigen dat alle AIT-producten dit doel kunnen bereiken. Het bewijs vertoont tot nu toe onvolkomenheden, maar er is een langetermijnstudie van Mola die keek naar allergeen-immunotherapie bij kinderen met graspollenallergie; hieruit bleek dat degenen die therapie kregen minder kans hadden om astma te ontwikkelen. Deze interviews zijn opgenomen tijdens de Rhinology Future Debates Brussel 2017 met Oliver Pfaar, David Price en Glenis Scadding.","og_url":"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/","url":"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/","name":"Allergeen-immunotherapie: Kan astmapreventie worden bereikt? - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png","datePublished":"2018-02-14T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/nl\/news\/allergeen-immunotherapie-kan-astmapreventie-worden-bereikt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/nl\/kies-uw-traject\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/nl\/news\/"},{"@type":"ListItem","position":3,"name":"Allergeen-immunotherapie: Kan astmapreventie worden bereikt?"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/nl\/#website","url":"https:\/\/www.euforea.org\/nl\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/nl\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/24259","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/comments?post=24259"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/24259\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media\/24266"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media?parent=24259"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/categories?post=24259"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/tags?post=24259"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}